Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Cowen Downgrades Clearside Biomedical (CLSD) to Market Perform
-
Clearside Biomedical (CLSD) Overreacted to DME Data, Catalysts Ahead - Cowen
-
Clearside Biomedical to Present at the Cowen and Company 38th Annual Health Care Conference
-
Clearside Biomedical to Present at the Cowen and Company 38th Annual Health Care Conference
-
Clearside Biomedical (CLSD) Prices 6.54M Shares at $13
-
Clearside Announces Pricing of Public Offering of Common Stock
-
Clearside Announces Pricing of Public Offering of Common Stock
-
UPDATE: Clearside Biomedical (CLSD) Announces Proposed $75M Common Share Offering
-
Clearside Announces Proposed Public Offering of Common Stock
-
Clearside Announces Proposed Public Offering of Common Stock
-
Pre-Open Movers 03/05: (CLSD) (XL) (GTXI) Higher; (DERM) (QCOM) (PK) Lower (more...)
-
Clearside Biomedical (CLSD) Enters $50M Stock Sale Agreement with Cowen
-
Clearside Biomedical (CLSD) Enters $50M ATM Offering Via Cowen
-
Clearside Biomedical, Inc. to Present at the Cowen and Company 37th Annual Health Care Conference
-
Clearside Biomedical (CLSD) Prices 4M Shares at $9
-
Clearside Biomedical, Inc. Announces Pricing of Public Offering of Common Stock
-
Clearside Biomedical (CLSD) Lower After Plans to Offer 4M Shares
-
Clearside Biomedical (CLSD) Announces $75M Common Stock Offering
-
Clearside Biomedical, Inc. Announces Proposed Offering of Common Stock
-
Cowen Starts Clearside Biomedical (CLSD) at Outperform
-
Clearside Biomedical (CLSD) IPO Opens Up 14%
-
Clearside Biomedical (CLSD) Prices 7.2M Common Stock IPO at $7/Share
-
Clearside Biomedical, Inc. Announces Pricing of Initial Public Offering

